Capricor Therapeutics Inc (CAPR)
5.31
+0.04
(+0.76%)
USD |
NASDAQ |
May 01, 16:00
5.31
0.00 (0.00%)
After-Hours: 17:48
Capricor Therapeutics Price to Book Value: 7.401 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 7.346 |
April 29, 2024 | 7.429 |
April 26, 2024 | 7.541 |
April 25, 2024 | 7.178 |
April 24, 2024 | 7.025 |
April 23, 2024 | 6.718 |
April 22, 2024 | 6.886 |
April 19, 2024 | 6.983 |
April 18, 2024 | 7.039 |
April 17, 2024 | 7.736 |
April 16, 2024 | 8.266 |
April 15, 2024 | 8.168 |
April 12, 2024 | 8.712 |
April 11, 2024 | 8.684 |
April 10, 2024 | 8.781 |
April 09, 2024 | 9.199 |
April 08, 2024 | 9.172 |
April 05, 2024 | 9.367 |
April 04, 2024 | 9.339 |
April 03, 2024 | 9.478 |
April 02, 2024 | 9.604 |
April 01, 2024 | 9.889 |
March 28, 2024 | 9.464 |
March 27, 2024 | 9.436 |
March 26, 2024 | 8.795 |
Date | Value |
---|---|
March 25, 2024 | 9.241 |
March 22, 2024 | 8.893 |
March 21, 2024 | 9.590 |
March 20, 2024 | 9.548 |
March 19, 2024 | 9.464 |
March 18, 2024 | 9.422 |
March 15, 2024 | 8.878 |
March 14, 2024 | 8.572 |
March 13, 2024 | 8.252 |
March 12, 2024 | 8.197 |
March 11, 2024 | 8.058 |
March 08, 2024 | 8.183 |
March 07, 2024 | 7.002 |
March 06, 2024 | 7.146 |
March 05, 2024 | 6.829 |
March 04, 2024 | 6.436 |
March 01, 2024 | 6.291 |
February 29, 2024 | 5.788 |
February 28, 2024 | 5.967 |
February 27, 2024 | 5.981 |
February 26, 2024 | 5.458 |
February 23, 2024 | 5.389 |
February 22, 2024 | 5.347 |
February 21, 2024 | 5.320 |
February 20, 2024 | 5.292 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7185
Minimum
Mar 10 2020
74.09
Maximum
Aug 28 2023
7.730
Average
3.82
Median
Jun 28 2022
Price to Book Value Benchmarks
Cutera Inc | -- |
Sarepta Therapeutics Inc | 14.31 |
PTC Therapeutics Inc | -- |
Solid Biosciences Inc | 2.851 |
AIM ImmunoTech Inc | 2.039 |
Price to Book Value Related Metrics
PS Ratio | 5.647 |
Price | 5.31 |
Earnings Yield | -15.63% |
Market Cap | 167.28M |